A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth
- PMID: 12831061
- DOI: 10.1023/a:1023841921971
A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth
Abstract
We put forward an algorithm describing the three principal interconnected sub-processes that influence tumor and vasculature dynamics: (i) tumor cell proliferation (ii) angiogenesis, that is, the formation and regression of immature vessels (IV), and (iii) maturation, i.e., the formation and destabilization of mature vessels (MV). This algorithm takes account of the crucial quantitative interactions of these sub-processes, occurring across the molecular, cellular and organ levels. Implementing this complex algorithm in a computer model, one can evaluate the correlations between various factors influencing angiogenesis and their influence on tumor progression at any given moment. Moreover, the computer simulations enable analysis of the versatile effects of drugs on the growth and decay of both the tumor and the immature and mature blood vessels, as well as on the induction of an array of relevant growth factors such as angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Simulation results suggest that vessel maturation and destabilization of MV drive the otherwise non-linearly growing system into a very dynamic region, having irregular, scale-invariant, fluctuations, around certain asymptotic values of all the involved quantities. Destabilization itself adequately explains the experimentally observed eventual decrease of tumor growth, with no need to implicate additional assumptions, such as a new tumor growth inhibitory, or anti-angiogenic, factors. Our results further suggest that mono-therapy alone can slow tumor growth, but is not capable of eliminating it altogether. In contrast, the combined treatment of anti-angiogenic and anti-maturation drugs causes prolonged suppression of tumor growth and a significant linear decrease in average tumor size. Laboratory experiments are warranted for validating our predictions and for providing in vivo evaluated parameters.
Similar articles
-
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.Am J Pathol. 2003 Jun;162(6):1913-26. doi: 10.1016/S0002-9440(10)64325-8. Am J Pathol. 2003. PMID: 12759248 Free PMC article.
-
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.Oncogene. 1999 Sep 20;18(38):5356-62. doi: 10.1038/sj.onc.1203035. Oncogene. 1999. PMID: 10498889 Review.
-
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
-
Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis.J Theor Biol. 2016 Jun 7;398:162-80. doi: 10.1016/j.jtbi.2016.03.002. Epub 2016 Mar 14. J Theor Biol. 2016. PMID: 26987523
-
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.Semin Oncol. 2002 Dec;29(6 Suppl 16):3-9. doi: 10.1053/sonc.2002.37265. Semin Oncol. 2002. PMID: 12516032 Review.
Cited by
-
Systems biology of the microvasculature.Integr Biol (Camb). 2015 May;7(5):498-512. doi: 10.1039/c4ib00296b. Epub 2015 Apr 2. Integr Biol (Camb). 2015. PMID: 25839068 Free PMC article. Review.
-
A systems biology view of blood vessel growth and remodelling.J Cell Mol Med. 2014 Aug;18(8):1491-508. doi: 10.1111/jcmm.12164. Epub 2013 Nov 17. J Cell Mol Med. 2014. PMID: 24237862 Free PMC article. Review.
-
An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.PLoS Comput Biol. 2011 Sep;7(9):e1002206. doi: 10.1371/journal.pcbi.1002206. Epub 2011 Sep 29. PLoS Comput Biol. 2011. PMID: 22022259 Free PMC article.
-
Oscillatory dynamics in a model of vascular tumour growth--implications for chemotherapy.Biol Direct. 2010 Apr 20;5:27. doi: 10.1186/1745-6150-5-27. Biol Direct. 2010. PMID: 20406447 Free PMC article.
-
Manipulating the microvasculature and its microenvironment.Crit Rev Biomed Eng. 2013;41(2):91-123. doi: 10.1615/critrevbiomedeng.2013008077. Crit Rev Biomed Eng. 2013. PMID: 24580565 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous